Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1255, 2000-01, pp. : 20-21
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Ribavirin effective in patients with chronic hepatitis B?
Inpharma, Vol. 1, Iss. 1248, 2000-01 ,pp. :
Access to resources
Recommend
Hepatitis B vaccination: to B or not to B?
Inpharma, Vol. 1, Iss. 1237, 2000-01 ,pp. :
Should Australia introduce lamivudine for chronic hep B?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 270, 2000-01 ,pp. :
To B or Not to B? Pharmaceutical Technology Innovation for Management of Hepatitis B
Pharmaceutical Innovation, Vol. 11, Iss. 4, 2002-06 ,pp. :
Lamivudine plus IFN- -2b: potential in hepatitis B?
Inpharma, Vol. 1, Iss. 1235, 2000-01 ,pp. :